OCULOSAN

This brand name is authorized in Cyprus, Hong Kong, Poland

Active ingredients

The drug OCULOSAN contains a combination of these active pharmaceutical ingredients (APIs):

1 Naphazoline UNII SC99GR1T5S - NAPHAZOLINE NITRATE

Naphazoline is a sympathomimetic amine with pronounced alpha adrenergic activity and as a consequence has vasoconstrictor activity. Read about Naphazoline

2 Zinc sulfate UNII 89DS0H96TB - ZINC SULFATE, UNSPECIFIED FORM

Zinc sulfate is a source of zinc which is an essential trace element and involved in a number of body enzyme systems. Severe deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections and failure to thrive in children. Read about Zinc sulfate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01GA51	Naphazoline, combinations	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GA Sympathomimetics used as decongestants
Discover more medicines within S01GA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 29782
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100248056, 100344127